Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein Occlusion

Aqueous Humor Levels of Vasoactive Molecules Correlate with Vitreous Levels and Macular Edema in Central Retinal Vein Occlusion

(2018) Hidetaka Noma et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Bevacizumab in Central Retinal Vein Occlusion: A Retrospective Analysis after 2 Years of Treatment

(2018) Andreas Stahl et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion: Perfused vs. Ischemic and Early vs. Late Treatment

(2012) Francis Char DeCroos et al.   CURRENT EYE RESEARCH

Intravitreal Bevacizumab in Central Retinal Vein Occlusion: 18-month Results of a Prospective Clinical Trial

(2011) Peep V. Algvere et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Efficacy of Ranibizumab in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion: Results From the Sham-Controlled ROCC Study

(2010) Bettina Kinge et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Results of bevacizumab as the primary treatment for retinal vein occlusions

(2010) M. S. Figueroa et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion

(2010) Alexandra Eva Hoeh et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intravitreal Bevacizumab (Avastin) in the Treatment of Macular Edema Associated With Perfused Retinal Vein Occlusion

(2010) Kuo-Hsuan Hung et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion

(2009)   ARCHIVES OF OPHTHALMOLOGY

Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion

(2009) Thomas Ach et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Ischaemic change after intravitreal bevacizumab (Avastin®) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion

(2008) Kwan Soo Kim et al.   ACTA OPHTHALMOLOGICA

Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion

(2008) Florian Rensch et al.   ACTA OPHTHALMOLOGICA

Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion

(2008) Richard F. Spaide et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions

(2008) Dante J. Pieramici et al.   OPHTHALMOLOGY